Effect of Vascular Risk Factors and Diseases on Mortality in Individuals with Dementia: A Systematic Review and Meta-Analysis

Journal of the American Geriatrics Society

Volumn 64, Issue 1, 2016, Pages 37-46

  Van De Vorst, Irene E ^a   Koek, Huiberdina L ^a   De Vries, Rehana ^a   Bots, Michiel L ^a   Reitsma, Johannes B ^a   Vaartjes, Ilonca ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

cardiovascular disease; dementia; meta analysis; prognosis; review

Indexed keywords

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; DEMENTIA; DIABETES MELLITUS; HAZARD RATIO; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; OBESITY; RISK ASSESSMENT; SEX; SMOKING; AGED; CARDIOVASCULAR DISEASE; COMPLICATION; HEALTH; META ANALYSIS; RISK FACTOR; SURVIVAL RATE; TRENDS;

AGED; CARDIOVASCULAR DISEASES; DEMENTIA; GLOBAL HEALTH; HUMANS; RISK FACTORS; SURVIVAL RATE;

EID: 84956624721     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13835     Document Type: Article

References (50)

1. Larson EB, Shadlen MF, Wang L, et al., Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004; 140: 501-509.
2. Ostbye T, Hill G, Steenhuis R,. Mortality in elderly Canadians with and without dementia: A 5-year follow-up. Neurology 1999; 53: 521-526.
3. Hoeymans N, van Loon AJM, van den Berg M, et al., Een gezonder nederland. kernboodschappen van de volksgezondheid toekomstverkenning 2014. Available at http://www.rivm.nl/dsresource?objectid=rivmp:251654&type=org&disposition=inline Accessed January 4, 2014.
4. Xie J, Brayne C, Matthews FE, Medical Research Council Cognitive Function and Ageing Study collaborators. Survival times in people with dementia: Analysis from population based cohort study with 14 year follow-up. BMJ 2008; 336: 258-262.
5. Guehne U, Riedel-Heller S, Angermeyer MC,. Mortality in dementia. Neuroepidemiology 2005; 25: 153-162.
6. Lee M, Chodosh J,. Dementia and life expectancy: What do we know? J Am Med Dir Assoc 2009; 10: 466-471.
7. Alzheimer's Association. Alzheimer's disease facts and figures. Alzheimers Dement 2013; 2013 (9): 208-245.
8. Fargo K, Bleiler L,. Alzheimer's association report. Alzheimers Dement 2014; 10: e47-e92.
9. Blom K, Emmelot-Vonk MH, Koek HD,. The influence of vascular risk factors on cognitive decline in patients with dementia: A systematic review. Maturitas 2013; 76: 113-117.
10. Moher D, Liberati A, Tetzlaff J, et al., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009; 339: b2535.
11. Hayden JA, van der Windt DA, Cartwright JL, et al., Assessing bias in studies of prognostic factors. Ann Intern Med 2013; 158: 280-286.
12. Freels S, Nyenhuis DL, Gorelick PB,. Predictors of survival in African American patients with AD, VaD, or stroke without dementia. Neurology 2002; 59: 1146-1153.
13. Magierski R, Kloszewska I, Sobow TM,. The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease. Neurol Neurochir Pol 2010; 44: 139-147.
14. Mortel KF, Meyer JS, Rauch GM, et al., Factors influencing survival among patients with vascular dementia and Alzheimer's disease. J Stroke Cerebrovasc Dis 1999; 8: 57-65.
15. Zhao Q, Zhou B, Ding D, et al., Prevalence, mortality, and predictive factors on survival of dementia in Shanghai, China. Alzheimer Dis Assoc Disord 2010; 24: 151-158.
16. Zilkens RR, Davis WA, Spilsbury K, et al., Earlier age of dementia onset and shorter survival times in dementia patients with diabetes. Am J Epidemiol 2013; 177: 1246-1254.
17. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
18. Higgins JP, Thompson SG, Spiegelhalter DJ,. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009; 172: 137-159.
19. Riley RD, Higgins JP, Deeks JJ,. Interpretation of random effects meta-analyses. BMJ 2011; 342: d549.
20. Go SM, Lee KS, Seo SW, et al., Survival of Alzheimer's disease patients in Korea. Dement Geriatr Cogn Disord 2013; 35: 219-228.
21. Bowen JD, Malter AD, Sheppard L, et al., Predictors of mortality in patients diagnosed with probable Alzheimer's disease. Neurology 1996; 47: 433-439.
22. Gambassi G, Landi F, Lapane KL, et al., Predictors of mortality in patients with Alzheimer's disease living in nursing homes. J Neurol Neurosurg Psychiatry 1999; 67: 59-65.
23. Mitchell SL, Kiely DK, Hamel MB, et al., Estimating prognosis for nursing home residents with advanced dementia. JAMA 2004; 291: 2734-2740.
24. Mitchell SL, Miller SC, Teno JM, et al., The advanced dementia prognostic tool: A risk score to estimate survival in nursing home residents with advanced dementia. J Pain Symptom Manage 2010; 40: 639-651.
25. Brown AF, Mangione CM, Saliba D, et al., Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 5 (Suppl Guidelines): S265-S280.
26. Rizzuto D, Fratiglioni L,. Lifestyle factors related to mortality and survival: A mini-review. Gerontology 2014; 60: 327-335.
27. Brookmeyer R, Corrada MM, Curriero FC, et al., Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002; 59: 1764-1767.
28. Lonnroos E, Kyyronen P, Bell JS, et al., Risk of death among persons with Alzheimer's disease: A national register-based nested case-control study. J Alzheimers Dis 2013; 33: 157-164.
29. Muller M, Smulders YM, de Leeuw PW, et al., Treatment of hypertension in the oldest old: A critical role for frailty? Hypertension 2014; 63: 433-441.
30. Gamba P, Testa G, Sottero B, et al., The link between altered cholesterol metabolism and Alzheimer's disease. Ann N Y Acad Sci 2012; 1259: 54-64.
31. Tikhonoff V, Casiglia E, Mazza A, et al., Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 2005; 53: 2159-2164.
32. Kiliaan AJ, Arnoldussen IA, Gustafson DR,. Adipokines: A link between obesity and dementia? Lancet Neurol 2014; 13: 913-923.
33. Kalmijn S, Curb JD, Rodriguez BL, et al., The association of body weight and anthropometry with mortality in elderly men: The Honolulu Heart Program. Int J Obes Relat Metab Disord 1999; 23: 395-402.
34. Chaudhry SI, Wang Y, Gill TM, et al., Geriatric conditions and subsequent mortality in older patients with heart failure. J Am Coll Cardiol 2010; 55: 309-316.
35. Zuccala G, Pedone C, Cesari M, et al., The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 2003; 115: 97-103.
36. Granger CB, Goldberg RJ, Dabbous O, et al., Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345-2353.
37. Alexander KP, Newby LK, Armstrong PW, et al., Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: A scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: In collaboration with the society of geriatric cardiology. Circulation 2007; 115: 2570-2589.
38. Alexander KP, Newby LK, Cannon CP, et al., Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: A scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: In collaboration with the Society of Geriatric Cardiology. Circulation 2007; 115: 2549-2569.
39. Helzner EP, Scarmeas N, Cosentino S, et al., Survival in Alzheimer disease: A multiethnic, population-based study of incident cases. Neurology 2008; 71: 1489-1495.
40. Hicks KL, Rabins PV, Black BS,. Predictors of mortality in nursing home residents with advanced dementia. Am J Alzheimers Dis Other Demen 2010; 25: 439-445.
41. Musini VM, Tejani AM, Bassett K, et al., Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009; 4: CD000028.
42. Collins R, Armitage J, Parish S, et al., Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004; 363: 757-767.
43. Shepherd J, Blauw GJ, Murphy MB, et al., Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002; 360: 1623-1630.
44. Beckett N, Peters R, Leonetti G, et al., Subgroup and per-protocol analyses from the hypertension in the very elderly trial. J Hypertens 2014; 32: 1478-87; discussion 1487.
45. Beishon LC, Harrison JK, Harwood RH, et al., The evidence for treating hypertension in older people with dementia: A systematic review. J Hum Hypertens 2014; 28: 283-287.
46. Stone NJ, Robinson JG, Lichtenstein AH, et al., 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014; 129 (25 Suppl 2): S1-S45.
47. Tsai P, Chen S, Lin K, et al., Survival of ethnic Chinese with Alzheimer's disease: A 5-year longitudinal study in Taiwan. J Geriatr Psychiatry Neurol 2007; 20: 172-177.
48. Delva F, Pimouguet C, Helmer C, et al., A simple score to predict survival with dementia in the general population. Neuroepidemiology 2013; 41: 20-28.
49. Koopmans RT, Ekkerink JL, van den Hoogen HJ, et al., Mortality in patients with dementia following admission to a nursing home: A 10-year analysis. Ned Tijdschr Geneeskd 1994; 138: 1169-1174.
50. van Dijk PT, Dippel DWJ, van der Meulen JH, Habbema JD,. Comorbidity and its effect on mortality in nursing home patients with dementia. J Nerv Ment Dis 1996; 184: 180-187.